Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
暂无分享，去创建一个
M. Bronstein | A. Spinola-Castro | S. Vencio | M. Czepielewski | N. Rassi | G. E. Wassermann | M. Cerqueira | O. Toffoletto | J. Afiune | Q. Garret | M. S. Faria | A. Neves | M. Cunha | R. Baradelli | D. G. Rodrigues | M. Scharf | C. Senn | N. R. Leite | M. C. Alegria